4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-018675
Chief Executive Officer sold 123,615 shares at an average $55.03 ($6,803,044)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2024-02-27 | Sale 10b5-1 | −62,810 | $55.00 | $3,454,550 | 3,043,619 | D: show line 1 in the form |
| Santos da Silva Jorge Chief Executive Officer | 2024-02-28 | Sale 10b5-1 | −56,065 | $55.00 | $3,083,575 | 2,987,554 | D: show line 2 in the form |
| Santos da Silva Jorge Chief Executive Officer | 2024-02-29 | Sale 10b5-1 | −4,740 | $55.89 | $264,919 | 2,982,814 | D: show line 3 in the form |
| Open-market sales · 123,615 sh · avg $55.03 · $6,803,044 | |||||||
Loading xslF345X05/ownership.xml…